ZEVRA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.52 USD | 0.00% |
|
0.00% | -30.99% |
Chart calendar Zevra Therapeutics, Inc.
6643514dde535f235b23b65f192.OtTWqcTZ0iDyF_0P5n1fXbpfI99Pl2v5kP-1P1wc8Pw.WZ6AxIiUgha1cM9rljIcEfssVqt60z3Pz5PqSRIxvrlYt4HglJCnQZ9WtA~8378c2560dc825551f1d7788c19ea1fe
Upcoming events on Zevra Therapeutics, Inc.
Past events on Zevra Therapeutics, Inc.
| 2024-04-08 03:45 pm | Needham Healthcare Conference |
| 2024-03-28 04:32 pm | Q4 2023 Earnings Release |
| 2024-03-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-18 04:00 pm | Roth Conference |
| 2024-03-05 02:10 pm | TD Cowen Health Care Conference |
| 2024-02-13 09:20 am | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-07 08:00 am | Q3 2023 Earnings Call |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-10-06 05:15 pm | Child Neurology Society Meeting |
| 2023-10-05 03:30 pm | Child Neurology Society Meeting - Poster No: 100 |
| 2023-09-27 03:00 pm | Cantor Global Healthcare Conference - Fireside Chat |
| 2023-09-13 08:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-07 | Psych Congress |
| 2023-08-31 08:30 am | Acquisiton of Acer Therapeutics by Zeva Therapeutics |
| 2023-08-14 08:30 am | Q2 2023 Earnings Call |
| 2023-08-14 07:30 am | Q2 2023 Earnings Release |
| 2023-06-22 09:30 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-04 10:20 am | Hypersomnia Foundation Beyond Sleepy Conference |
| 2023-06-02 | Associated Professional Sleep Societies Meeting |
| 2023-05-16 03:05 pm | RBC Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,8 17,0 -24.39% | 13,3 12,9 3.13% | 28,7 28,3 1.23% | 10,5 11,2 -6.99% | 27,5 26,0 5.71% | 29,3 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -41,6 -38,6 -7.67% | 0,00 -54,2 - | -49,6 |
|
EBIT Million USD | Released Forecast Spread | -20,3 -17,5 -16.45% | -5,61 -3,72 -50.9% | 7,73 7,94 -2.65% | -42,5 -35,6 -19.47% | -49,6 -47,4 -4.67% | -67,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -23,4 -4.99% | -12,8 -11,0 -16.06% | -8,52 -25,3 66.38% | -42,3 -40,0 -5.69% | -46,0 -43,0 -6.98% | -69,2 |
|
Net income Million USD | Released Forecast Spread | -24,5 -23,3 -5.15% | -12,8 -11,0 -16.27% | -62,9 -25,3 -148.15% | -41,5 -39,3 -5.78% | -46,0 -43,0 -6.99% | -69,2 |
|
EPS USD | Released Forecast Spread | -13,3 -12,3 -7.79% | -3,21 -2,75 -16.73% | -2,11 -0,86 -146.78% | -1,20 -1,12 -7.62% | -1,30 -1,18 -9.86% | -1,59 |
| Announcement Date | 28/02/20 | 11/03/21 | 30/03/22 | 07/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,58 2,24 15.53% | 3,97 3,07 29.36% | 1,30 1,75 -25.61% | 2,87 3,01 -4.59% | 2,32 3,10 -25.19% | 2,88 2,66 8.43% | 8,47 3,03 179.23% | 2,90 3,38 -14.33% | 13,2 11,7 12.6% | 3,76 | 4,65 | 5,75 | 15,1 | 13,7 |
|
EBITDA Million USD | Released Forecast Spread | -6,23 -5,50 -13.24% | -8,95 -5,90 -51.75% | -12,8 -9,00 -42.72% | -6,57 -12,1 45.73% | -15,3 -11,3 -35.42% | -29,8 | -20,4 | -16,0 | -13,9 | 0,60 | ||||
|
EBIT Million USD | Released Forecast Spread | -2,84 -2,63 -7.98% | -1,86 -2,01 7.65% | -24,8 -4,86 -409.66% | -6,63 -6,15 -7.68% | -9,25 -6,74 -37.21% | -12,9 -8,55 -51.24% | -6,65 -12,9 48.56% | -15,4 -11,3 -35.53% | -14,7 -12,5 -17.65% | -20,3 | -18,7 | -18,3 | -9,65 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,67 -2,60 -2.81% | -1,87 -1,91 2.25% | -24,8 -4,80 -415.93% | -6,65 -5,60 -18.8% | -9,06 -6,76 -33.9% | -11,9 -8,66 -37.03% | -5,16 -12,9 60.04% | -13,9 -11,1 -24.89% | -15,2 -12,1 -24.73% | -20,4 | -19,0 | -18,5 | -9,76 | |
|
Net income Million USD | Released Forecast Spread | -2,70 -2,60 -4.12% | -1,86 -1,91 2.46% | -24,0 -4,80 -401.03% | -6,62 -5,60 -18.21% | -9,02 -6,76 -33.4% | -11,8 -8,65 -35.97% | -5,08 -12,9 60.58% | -14,0 -11,1 -26.58% | -15,2 -12,1 -24.79% | -20,3 | -19,0 | -18,5 | -9,76 | |
|
EPS USD | Released Forecast Spread | -0,08 -0,08 -6.67% | -0,05 -0,06 9.09% | -0,70 -0,14 -400% | -0,19 -0,16 -21.27% | -0,26 -0,19 -40.54% | -0,34 -0,23 -46.24% | -0,15 -0,34 56.31% | -0,40 -0,30 -34.45% | -0,40 -0,27 -49.07% | -0,48 | -0,43 | -0,42 | -0,22 | -0,29 |
| Announcement Date | 30/03/22 | 12/05/22 | 11/08/22 | 09/11/22 | 07/03/23 | 15/05/23 | 14/08/23 | 07/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for Zevra Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZVRA Stock
- Calendar Zevra Therapeutics, Inc.
